IMMB WOW Proprietary Rights Entry into a Mater
Post# of 145205
[b]IMMB [/b]WOW >> Proprietary Rights
Entry into a Material Definitive Agreement.
On January 30, 2009 the Company entered into an exclusive licensing agreement with Ara Ghanime and Harry Zhabilov for the licensing of the patent underlying the IPF treatment for HIV/AIDS. Pursuant to the licensing agreement, Ara Ghanime and Harry Zhabilov received 98% ownership of Immunotech consisting of 60,000,000 common shares of the Company.
AGREEMENT RE CONSIDERATION FOR LICENSING OF PATENT
THIS AGREEMENT is made and entered into as of this the 30 th day of January, 2009, by and between IMMUNOTECH LABORATORIES, INC., a Nevada corporation ( “Immunotech”), HARRY ZHABILOV and ARA GHANIME.
W I T N E S S E T H:
WHEREAS, by a separate agreement, The Zhabilov Trust has exclusively licensed to Immunotech and Immunotech wishes to exclusively license from The Zhabilov Trust all of The Zhabilov Trust's rights under patents, patent applications and know-how (including U.S. Patent and Trademark Office serial number 11/177,427 filed on 7/11/2005/Cislo & Thomas LLP’s Docket Number 06-16256/ US Patent Application 20060104992 dated May 18, 2006 that Inventor Harry H. Zhabilov, together with his wife Diana Zhabilov, had assigned on July 18, 2006 to The Zhabilov Trust) related to IPF specific to the HIV/AIDS treatment ONLY ; and
(0)
(0)